cyclohexanol has been researched along with lithium in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gore, MG; Greasley, PJ; Ragan, CI | 1 |
| Gee, NS; Knowles, MR; McAllister, G; Ragan, CI | 1 |
| Cama, HR; John, J; Singh, H | 1 |
| Rice, FA | 1 |
| Rothschild, AJ | 1 |
| Boudino, FD; Chiang, ST; Hicks, DR; Parker, VD; Troy, SM | 1 |
| Duman, RS; Heninger, GR; Malison, RT; Nestler, EJ; Price, LH | 1 |
| Yonkers, KA | 1 |
| Hirschfeld, RM | 1 |
| Matthews, HR; Reisert, J | 1 |
| Dijken, WA; Haffmans, J; Hoencamp, E; Huijbrechts, IP | 1 |
| Benabarre, A; Colom, F; Goikolea, JM; Martinez-Arán, A; Reinares, M; Torrent, C; Vieta, E | 1 |
| Hazell, P | 1 |
| Basinski, J; Begley, A; Dew, MA; Farhi, P; Mulsant, BH; Reynolds, CF; Whyte, EM | 1 |
| Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kupka, RW; Leverich, GS; Martinez, MI; McElroy, SL; Nolen, WA; Post, RM; Suppes, T | 1 |
| Valenstein, M | 1 |
| Amsterdam, JD; Shults, J; Wang, G | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Haskett, R; Isenberg, K; Kimball, J; Lasater, B; McCall, WV; Prudic, J; Rosenquist, PB; Sackeim, HA | 1 |
| Amsterdam, J; Guerra, MW; Shults, J; Ten-Have, T | 1 |
| Brus, O; Carlborg, A; Engström, I; Ljung, T; Nordenskjöld, A; von Knorring, L | 1 |
4 review(s) available for cyclohexanol and lithium
| Article | Year |
|---|---|
The diagnosis and treatment of late-life depression.
Topics: Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Trazodone; Triazoles; Venlafaxine Hydrochloride | 1996 |
Antidepressants in the treatment of premenstrual dysphoric disorder.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Humans; Lithium; Luteal Phase; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Terminology as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Pharmacotherapy of borderline personality disorder.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Borderline Personality Disorder; Clinical Trials as Topic; Cyclohexanols; Female; Humans; Lithium; Male; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Depression in children and adolescents.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Hypericum; Lithium; Monoamine Oxidase Inhibitors; Phytotherapy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
8 trial(s) available for cyclohexanol and lithium
| Article | Year |
|---|---|
Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithium.
Topics: Administration, Oral; Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Desvenlafaxine Succinate; Drug Administration Schedule; Drug Interactions; Humans; Lithium; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1996 |
Lithium augmentation of venlafaxine: an open-label trial.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antimanic Agents; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2000 |
A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Bupropion; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lithium; Male; Psychiatric Status Rating Scales; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Keeping our eyes on STAR*D.
Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Placebos; Research Design; Tranylcypromine; Treatment Outcome; Triiodothyronine; Venlafaxine Hydrochloride | 2006 |
Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
Topics: Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Middle Aged; Nortriptyline; Quality of Life; Time Factors; Venlafaxine Hydrochloride | 2011 |
Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antimanic Agents; Cognition; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Sample Size; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
10 other study(ies) available for cyclohexanol and lithium
| Article | Year |
|---|---|
Bovine inositol monophosphatase: development of a continuous fluorescence assay of enzyme activity.
Topics: Animals; Cattle; Cyclohexanols; Fluorescence; Hymecromone; Kinetics; Lithium; Magnesium; Organophosphorus Compounds; Phosphoric Monoester Hydrolases; Spectrophotometry | 1992 |
The effects of substrates, products and other ligands on the susceptibility of inositol monophosphatase to proteolysis by endoprotease lys-C.
Topics: Cyclohexanols; Endopeptidases; Inositol Phosphates; Ligands; Lithium; Magnesium; Metalloendopeptidases; Organophosphorus Compounds; Phosphoric Monoester Hydrolases; Substrate Specificity | 1991 |
Preparation and properties of hydroxy apocarotenals obtained from zeaxanthin.
Topics: Acetates; Aluminum; Animals; Antimony; Biological Assay; Carotenoids; Chemical Phenomena; Chemistry; Chlorides; Chromatography; Cyclohexanes; Cyclohexanols; Gastric Mucosa; Hydrogen Peroxide; Intestinal Mucosa; Lithium; Lutein; Magnetic Resonance Spectroscopy; Oxidation-Reduction; Plants; Potassium Permanganate; Rats; Spectrophotometry; Spectrophotometry, Infrared; Structure-Activity Relationship; Vitamin A Deficiency | 1973 |
Synthesis of 3-hydroxy-3-(hydroxymethyl)-5-methyl-1,2-cyclohexanedione, a hydrolytic product of leucogenenol.
Topics: Acetals; Acetone; Alcohols; Aluminum; Chemical Phenomena; Chemistry; Chromatography, Gas; Chromatography, Thin Layer; Cyclohexanes; Cyclohexanols; Diazomethane; Hydrolysis; Hydroxylation; Infrared Rays; Ketones; Lithium; Magnetic Resonance Spectroscopy; Oxidation-Reduction; Spectrophotometry; Spiro Compounds; Stereoisomerism | 1972 |
Efficacy of papaverine addition for treatment-refractory major depression.
Topics: Buspirone; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lithium; Middle Aged; Papaverine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Na+-dependent Ca2+ extrusion governs response recovery in frog olfactory receptor cells.
Topics: Adaptation, Physiological; Animals; Calcium; Calcium Signaling; Choline; Cilia; Cyclohexanols; Cyclooxygenase Inhibitors; Electrophysiology; Eucalyptol; Lipotropic Agents; Lithium; Menthol; Monoterpenes; Niflumic Acid; Olfactory Receptor Neurons; Rana temporaria; Smell; Sodium; Sodium-Calcium Exchanger; Solvents; Terpenes | 1998 |
Consensus guidelines outline drug selection and sequencing options for bipolar disorder.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Practice Guidelines as Topic; Valproic Acid | 2000 |
Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Female; Humans; Lithium; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2010 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
The analysis of binary longitudinal data with time-dependent covariates.
Topics: Antidepressive Agents, Second-Generation; Computer Simulation; Cyclohexanols; Data Interpretation, Statistical; Depression; Humans; Likelihood Functions; Lithium; Logistic Models; Longitudinal Studies; Regression Analysis; Venlafaxine Hydrochloride | 2012 |